CCEL

Cryo-Cell International's stock price has declined over the past six months, with a share price of $3.52 as of April 29, 2026, a 32.95% decrease from April 30, 2025. The stock traded between $2.72 and $6.35 over the past 52 weeks. In March 2026, the company received a notice from NYSE American regarding non-compliance with listing standards, but in May 2026, NYSE American accepted the company's plan to regain compliance, granting a compliance period through September 9, 2027. The company reported fiscal year 2025 consolidated revenue of $31.6 million and a net loss of $2.4 million.